Proprietary Database, Market Surveys, Strategic Consultation & Advisory Services, Industry & Competitive Intelligence — Revenue, Volume, Production, Trade Analysis, Market Size, Share, Forecast, Drivers, Trends, Growth Opportunities, ESG and more.
| Data Timeline | Historical Data: 2022–2025 | Base Year: 2025 | Forecast Period: 2026–2034 |
|---|---|
| Type Segment | Haemodialysis, Peritoneal dialysis |
| End Users Segment | Hospitals dialysis, Home Care dialysis |
| Dialyzers Material Type Segment | Synthetic Dialyzers, Cellulose-Based Dialyzers |
|---|---|
| Flux Type Segment | High-Flux, Dialyzers, low Flux Dialyzers, Bloodlines Sets and tubes, Hemodialysis Concentrates/Dialysates, Alkaline Concentrates, Acidic Concentrates, Hemodialysis Access Products, AV Fistula Needles, Arteriovenous Grafts, Central Venous Catheters, Other Hemodialysis Consumables |
| Hemodialysis Modality Segment | Conventional Hemodialysis, Short Daily Hemodialysis, Nocturnal Hemodialysis (NHD) |
| Hemodialysis Water Treatment Systems Segment | Central Water Disinfection Systems, Portable Water Disinfection Systems |
| Disease Indication Segment | Acute Kidney Infections, ESRD, Septic Shock, Multi-Organ Failure, Others |
| Peritoneal Dialysis Modality Segment | Continuous Ambulatory Peritoneal Dialysis (CAPD), Ambulatory Peritoneal Dialysis (APD) |
| Usage Segment | Device, Consumables, Services, Catheters |
| Regions & Countries |
|
Country-level data · Company profiles · Editable dataset · Analyst consultation included.
Charts are illustrative — exact values, country-level breakdowns, and full forecast in the paid report. Request a Free Sample PDF.
To learn more about market share and segmentation, request the free sample pages.
Nipro Medical Corporation a leading manufacturer and supplier of renal, vascular, and medical-surgical products, announces the launch of SURDIAL DX Haemodialysis System in the U.S. Haemodialysis System is developed to create an optimum dialysis treatment experience for patients and clinicians. Moreover, regarding the machine’s performance and features, Nipro offers comprehensive services and an extensive training certification curriculum to support customers and to differentiate themselves from the current dialysis system in the U.S.
Baxter International Inc. a global innovator in renal care, announced today the launch of the Sharesource Analytics 1.0 premium module, the next generation of digital health for home-based peritoneal dialysis patients. Sharesource Analytics 1.0 is a clinical management resource within the Sharesource remote patient management platform that provides healthcare professionals with a comprehensive dashboard containing simplified trend data from their home dialysis patients’ treatment. Baxter plans to launch Sharesource Analytics 1.0 globally initiating in the United States, on a rolling basis over the next year, and making it available by subscription.
| Company | 2022 (A) | 2023 (A) | 2024 (A) | 2025 (A) |
|---|---|---|---|---|
| Baxter | ••• | ••• | ••• | ••• |
| B Braun Melsungen AG | ••• | ••• | ••• | ••• |
| Fresenius Medical Care AG | ••• | ••• | ••• | ••• |
| Medtronic | ••• | ••• | ••• | ••• |
| Asahi Kasei Medical Co | ••• | ••• | ••• | ••• |
| Nipro Corporation | ••• | ••• | ••• | ••• |
| DaVita; BD | ••• | ••• | ••• | ••• |
| Nikkiso Co Ltd | ••• | ••• | ••• | ••• |
| Cantel Medical | ••• | ••• | ••• | ••• |
| Becton Dickinson and Company | ••• | ••• | ••• | ••• |
| Nikkiso Co. Ltd | ••• | ••• | ••• | ••• |
| Toray Industries | ••• | ••• | ••• | ••• |
| Quanta Dialysis Technologies | ••• | ••• | ••• | ••• |
| Diaverum | ••• | ••• | ••• | ••• |
| Medtronic Plc | ••• | ••• | ••• | ••• |
Revenue data requires full access. *2nd & 3rd tier companies available on enquiry.
Request company profile for validation →As per the latest report of Cognative Market Research, The Hemodialysis, and Peritoneal Dialysis market was valued at USD 75.95 billion in 2022 and is projected to reach USD 104.75 billion by 2030, registering a CAGR of 4.5% for the forecast period 2023-2030.
The Hemodialysis and Peritoneal Dialysis Market is valued at USD 75.95 Billion in 2022 and is expected to reach 104.75 Billion in 2030, registering a CAGR of 4.5% in the forecast period 2023-2030
Hemodialysis is a treatment to penetrate waste and water from the blood, as this function is carried out by kidneys when they perform well and are healthy. Hemodialysis helps to control blood pressure and maintain the balance of important minerals, like potassium, sodium, and calcium in the blood. The blood is filtered from the body through a man-made membrane called a dialyzer. Peritoneal dialysis is a treatment for kidney failure that helps the covering of the abdomen filter the blood inside the body. An increase in the pervasiveness of the incidence of End-Stage Renal diseases is driving the market to grow.
Based on product, the market is further fragmented into Devices, Consumables Services, and Catheters. The service segment controls the market in 2021, by 55.1%. This can be associated with an increase in the service providers in the pervasiveness of ESRD. Moreover, numerous major dialysis service providers and planning to expand their service by starting and purchasing new dialysis centers all over the world, which is predicted to augment the segment growth. The consumables segment is anticipated to enlarge at the highest CAGR during the upcoming period. significant finance from the government to increase patient safety and patient-centered care, are predicted to show segment growth over the upcoming period. Companies are manufacturing catheters made up of sophisticated materials opposing chemicals like alcohol, peroxides, and iodine. It may help to expand the life of catheters and make the chances low of malfunctioning. In addition, the demand for antimicrobial-coated catheters is growing which reduces the rate of bloodstream infections
★ Reviews
Rate this report
| Type | Haemodialysis, Peritoneal dialysis |
| End Users | Hospitals dialysis, Home Care dialysis |
| Dialyzers Material Type | Synthetic Dialyzers, Cellulose-Based Dialyzers |
| Flux Type | High-Flux, Dialyzers, low Flux Dialyzers, Bloodlines Sets and tubes, Hemodialysis Concentrates/Dialysates, Alkaline Concentrates, Acidic Concentrates, Hemodialysis Access Products, AV Fistula Needles, Arteriovenous Grafts, Central Venous Catheters, Other Hemodialysis Consumables |
| Hemodialysis Modality | Conventional Hemodialysis, Short Daily Hemodialysis, Nocturnal Hemodialysis (NHD) |
| Hemodialysis Water Treatment Systems | Central Water Disinfection Systems, Portable Water Disinfection Systems |
| Disease Indication | Acute Kidney Infections, ESRD, Septic Shock, Multi-Organ Failure, Others |
| Peritoneal Dialysis Modality | Continuous Ambulatory Peritoneal Dialysis (CAPD), Ambulatory Peritoneal Dialysis (APD) |
| Usage | Device, Consumables, Services, Catheters |
| List of Competitors | Baxter, B Braun Melsungen AG, Fresenius Medical Care AG, Medtronic, Asahi Kasei Medical Co, Nipro Corporation, DaVita; BD, Nikkiso Co Ltd, Cantel Medical, Becton Dickinson and Company, Nikkiso Co. Ltd, Toray Industries, Quanta Dialysis Technologies, Diaverum, Medtronic Plc |
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Cognitive Market Research employs "The Full Truth™" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Supriya Yadav and team for the Hemodialysis and Peritoneal Dialysis Market Analysis Market analysis.
Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.
Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.
Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.
Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.
Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.
To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.
We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the Hemodialysis and Peritoneal Dialysis Market Analysis market.
Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the hemodialysis and peritoneal dialysis market analysis ecosystem — validated by our global panel of 10,000+ industrial respondents.
Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.
Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.
Tell us the specific segments, regions, or companies you need — and we will tailor the deliverable to your requirements.